Quantcast
Last updated on April 25, 2014 at 5:24 EDT

Latest hypoglycemia Stories

2011-09-28 15:04:04

Researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine have identified a powerful molecular pathway that regulates the liver's management of insulin and new glucose production, which could lead to new therapies for diabetes. The findings were published online this week in Diabetes, a journal of the American Diabetes Association. Usually, the liver stores excess blood sugar as glycogen, which it...

2011-09-27 17:48:18

Surgeons from Boston Medical Center (BMC) have found that in diabetic patients undergoing coronary artery bypass graft (CABG) surgery, aggressive glycemic control does not result in any significant improvement of clinical outcomes as compared with moderate control. The findings, which appear in this month's issue of Annals of Surgery, also found the incidence of hypoglycemic events increased with aggressive glycemic control. Currently, 40 percent of all patients undergoing CABG suffer from...

2011-09-26 07:00:00

A recent study conducted on older (age 65 and over) individuals with Type 2 diabetes found that they demonstrated less awareness of hypoglycemic (low blood glucose) episodes than middle-aged (age 39-64) diabetics as reported by DiabeticLive.com. Tampa, FL (PRWEB) September 26, 2011 New Study Shows Older Diabetics Are Less Aware of Hypoglycemic Symptoms: A recent study conducted on older (age 65 and over) individuals with Type 2 diabetes found that they demonstrated less awareness of...

2011-09-21 07:00:00

A recent Phase III investigation by has demonstrated that a new medication for the treatment of Type 2 diabetes significantly lowers blood glucose levels in adults while exhibiting few side effects and maintaining positive results over the duration of the study as reported by DiabeticLive.com. Tampa, FL (PRWEB) September 21, 2011 New Type 2 Diabetes Medication Reduces Blood Glucose Safely: A recent Phase III investigation has demonstrated that a new medication for the treatment of Type 2...

2011-09-19 06:00:00

HAYWARD, Calif., Sept. 19, 2011 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner(TM) Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union. This CE Mark certifies that the OptiScanner has met all relevant European Union consumer safety, health and environmental requirements, allowing it...

2011-09-13 05:15:00

THE WOODLANDS, Texas, Sept. 13, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, reported positive data from a recently completed clinical trial and mechanistic study of LX4211, a dual inhibitor of the sodium glucose transporters 1 and 2 (SGLT1 and SGLT2). The favorable safety profile and effects on multiple parameters of glycemic control and cardiovascular health in healthy...

2011-09-09 07:00:00

Research has shown that a diabeticâs sweat pattern undergoes changes when blood glucose levels drop too low. Now a sweat meter developed jointly at the University of Olso in Norway and the National Hospital may be able to monitor sweat patterns to determine irregularities in blood glucose levels and send an alert via text message before the patient suffers an attack. Tampa, FL (PRWEB) September 09, 2011 Sweat Meter May Alert Diabetics to Low Blood Glucose: Type 2 diabetics...

2011-09-08 07:00:00

PHILADELPHIA, Sept. 8, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System. The company expects to complete and announce the results of the study in the near-term. "Initiating the clinical study of...

2011-08-09 07:00:00

PHILADELPHIA, Aug. 9, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced the unveiling of a much anticipated demonstration video on the Company's website at www.echotx.com. The new video showcases the features and ease of use of the Symphony continuous glucose...

2011-08-01 14:33:51

Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional. They did find, however, that when aiming to keep blood glucose levels at the lower intensive level, the chance of damaging small blood vessels in the body, potentially leading to damage in the eyes and kidneys, is reduced. But aiming for this lower level with the more intensive glucose control substantially...


Latest hypoglycemia Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »